Use of a T Cell–Based Assay for Monitoring Efficacy of Antituberculosis Therapy
Open Access
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (5), 754-756
- https://doi.org/10.1086/381754
Abstract
Monitoring the efficacy of antituberculosis therapy is crucial both for the individual patient and for better control of the spread of tuberculosis. We studied 18 patients with microbiologically confirmed tuberculosis, both at the time of diagnosis and 3 months after they started therapy, using an in vitro assay that detects T cell–mediated interferon-γ response to selected peptides of Mycobacterium tuberculosis–specific early secretory antigenic target 6 (ESAT-6) protein. All patients had positive results at diagnosis; however, 3 months later, the response to ESAT-6 peptides was still detectable only in the 5 patients with microbiological isolation and/or absence of clinical improvement after treatment. On the basis of these data, we conclude that our assay is a useful tool in monitoring the efficacy of antituberculosis therapy.Keywords
This publication has 13 references indexed in Scilit:
- Proteins and Antigens ofMycobacterium tuberculosisPublished by American Society for Microbiology ,2014
- Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreakThe Lancet, 2003
- Identification of Early Secretory Antigen Target-6 Epitopes for the Immunodiagnosis of Active TuberculosisMolecular Medicine, 2003
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Tuberculin Skin Testing and In Vitro T Cell Responses to ESAT‐6 and Culture Filtrate Protein 10 after Infection withMycobacterium marinumorM. kansasiiThe Journal of Infectious Diseases, 2002
- Increasing CD4+T Cells Specific for Tuberculosis Correlate with Improved Clinical Immunity after Highly Active Antiretroviral TherapyAIDS Research and Human Retroviruses, 2002
- Identification and Characterization of the ESAT-6 Homologue ofMycobacterium lepraeand T-Cell Cross-Reactivity withMycobacterium tuberculosisInfection and Immunity, 2002
- Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of TreatmentPublished by The American Association of Immunologists ,2001
- Enumeration of T Cells Specific for RD1‐Encoded Antigens Suggests a High Prevalence of LatentMycobacterium tuberculosisInfection in Healthy Urban IndiansThe Journal of Infectious Diseases, 2001
- Sequestration of T Lymphocytes to Body Fluids in Tuberculosis: Reversal of Anergy following ChemotherapyThe Journal of Infectious Diseases, 1999